Get App Open
In App
Credit Cards
Open App
you are here:

Mankind Pharma Ltd.

BSE: 543904 | NSE: MANKIND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE634S01028 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 14, 16:00
2434.00 -7.80 (-0.32%)
Volume
AVERAGE VOLUME
5-Day
23,200
10-Day
23,982
30-Day
25,051
7,581
  • Prev. Close

    2441.80

  • Open Price

    2440.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 14, 15:57
2438.10 -4.40 (-0.18%)
Volume
AVERAGE VOLUME
5-Day
462,327
10-Day
559,087
30-Day
795,408
431,056
  • Prev. Close

    2442.50

  • Open Price

    2436.40

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2438.10 (39)

Financials

Profit & Loss account of Mankind Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 9,497.80 9,263.66 8,120.57 7,240.86 5,486.16  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 9,497.80 9,263.66 8,120.57 7,240.86 5,486.16  
Total Operating Revenues 9,497.80 9,264.81 8,127.15 7,257.04 5,529.60  
Other Income 493.21 266.64 162.78 162.73 148.08  
Total Revenue 9,991.01 9,531.45 8,289.94 7,419.77 5,677.68  
EXPENSES  
Cost Of Materials Consumed 800.43 861.74 711.05 772.24 494.53  
Purchase Of Stock-In Trade 1,809.96 2,071.92 1,865.82 2,014.37 1,541.89  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -13.50 -25.36 267.89 -352.01 -254.25  
Employee Benefit Expenses 2,131.67 1,982.10 1,701.38 1,443.83 1,106.14  
Finance Costs 371.76 14.57 27.75 43.83 7.98  
Depreciation And Amortisation Expenses 378.01 317.61 269.58 120.98 78.19  
Other Expenses 2,190.87 2,049.30 1,883.64 1,578.99 1,263.00  
Total Expenses 7,685.02 7,271.88 6,727.10 5,622.23 4,237.47  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,305.99 2,259.57 1,562.84 1,797.54 1,440.21  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 2,305.99 2,259.57 1,562.84 1,797.54 1,440.21  
Tax Expenses-Continued Operations  
Current Tax 469.93 416.56 296.00 399.58 344.89  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -48.19 19.60 30.30 49.09 8.84  
Tax For Earlier Years 0.00 0.00 -11.72 13.74 2.10  
Total Tax Expenses 421.74 436.16 314.58 462.41 355.83  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,884.25 1,823.41 1,248.26 1,335.13 1,084.37  
Profit/Loss From Continuing Operations 1,884.25 1,823.41 1,248.26 1,335.13 1,084.37  
Profit/Loss For The Period 1,945.48 1,823.41 1,248.26 1,335.13 1,084.37  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 48.16 45.52 31.16 33.33 27.07  
Diluted EPS (Rs.) 48.07 45.45 31.16 33.33 27.07  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.00 0.00 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970